Phosphodiesterase-4 activity: A critical modulator of atrial contractility and arrhythmogenesis

Journal of the American College of Cardiology

Volumn 59, Issue 24, 2012, Pages 2191-2192

  Van Wagoner, David R ^a   Lindsay, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

atrial fibrillation; calcium channel; calcium cycling; human atrial myocytes; phosphodiesterase activity

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE IV;

ARRHYTHMOGENESIS; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART ATRIUM CONTRACTILITY; HEART ATRIUM FIBRILLATION; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE;

EID: 84861906107     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.027     Document Type: Editorial

References (11)

1. 2+ currents and human atrial fibrillation. Circ Res 1999;85:428-36.
2. Benjamin EJ, Chen PS, Bild DE, et al. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation 2009;119:606-18.
3. Li Q, Himmel HM, Ravens U. Effects of the new phosphodiesterase- III inhibitor R80122 on contractility and calcium current in human cardiac tissue. J Cardiovasc Pharmacol 1994;24:133-43. (Pubitemid 24189611)
4. Christ T, Engel A, Ravens U, Kaumann AJ. Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through beta(2)- adrenoceptors than the effects of (-)-noradrenaline through beta (1)-adrenoceptors in human atrial myocardium. Naunyn Schmiedebergs Arch Pharmacol 2006;374:249-53. (Pubitemid 44819257)
5. Christ T, Galindo-Tovar A, Thoms M, Ravens U, Kaumann AJ. Inotropy and L-type Ca2+ current, activated by beta1- and beta2- adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart. Br J Pharmacol 2009;156:62-83.
6. Molina CE, Leroy J, Richter W, et al. Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias. J Am Coll Cardiol 2012;59:2182-90.
7. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22: 983-8.
8. Bevan S, Porteous L, Sitzer M, Markus HS. Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis. Stroke 2005;36:949-53. (Pubitemid 40629282)
9. Milton AG, Aykanat VM, Hamilton-Bruce MA, Nezic M, Jannes J, Koblar SA. Association of the phosphodiesterase 4D (PDE4D) gene and cardioembolic stroke in an Australian cohort. Int J Stroke 2011;6:480-6.
10. Ellinor PT, Lunetta KL, Glazer NL, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010; 42:240-4.
11. Pfeufer A, van NC, Marciante KD, et al. Genome-wide association study of PR interval. Nat Genet 2010;42:153-9.